FABP2 and COVID-19: As seen in Figure 4A, the levels of FABP2 were higher (p = 0.0013) in the plasma of COVID-19 patients compared with healthy individuals, supporting the assertion that subjects with COVID-19 infection exhibit increased permeability of the gut barrier.